Selected research
Market Analysis & Forecast
Global Vitamin B12 Series API Market Analysis and Forecast 2026-2032
Market perspective
The global Vitamin B12 Series API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Vitamin B12 Series API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Vitamin B12 Series API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Vitamin B12 Series API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Vitamin B12 Series API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Vitamin B12 Series API include EUROAPI, Eisai Co., Ltd, HTBA, North China Pharmaceutical Company, Ningxia Kingvit Pharmaceutical, Cspc Holdings Company and Yufeng Industry Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Vitamin B12 Series API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Vitamin B12 Series API, also provides the sales of main regions and countries. Of the upcoming market potential for Vitamin B12 Series API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vitamin B12 Series API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vitamin B12 Series API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vitamin B12 Series API sales, projected growth trends, production technology, application and end-user industry.
Vitamin B12 Series API Segment by Company
EUROAPI
Eisai Co., Ltd
HTBA
North China Pharmaceutical Company
Ningxia Kingvit Pharmaceutical
Cspc Holdings Company
Yufeng Industry Group
Vitamin B12 Series API Segment by Type
Adenosylcobalamin
Cyanocobalamin
Hydroxocobalamin
Methylcobalamin
Vitamin B12 Series API Segment by Application
Oral Formulation
Sprays
Injectable Formulation
Vitamin B12 Series API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin B12 Series API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vitamin B12 Series API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin B12 Series API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Vitamin B12 Series API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Vitamin B12 Series API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vitamin B12 Series API sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Adenosylcobalamin
- Cyanocobalamin
- Hydroxocobalamin
- Methylcobalamin
Applications
- Oral Formulation
- Sprays
- Injectable Formulation
Companies covered
- EUROAPI
- Eisai Co., Ltd
- HTBA
- North China Pharmaceutical Company
- Ningxia Kingvit Pharmaceutical
- Cspc Holdings Company
- Yufeng Industry Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Vitamin B12 Series API Market by Type
- 1.2.1 Global Vitamin B12 Series API Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Adenosylcobalamin
- 1.2.3 Cyanocobalamin
- 1.2.4 Hydroxocobalamin
- 1.2.5 Methylcobalamin
- 1.3 Vitamin B12 Series API Market by Application
- 1.3.1 Global Vitamin B12 Series API Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Oral Formulation
- 1.3.3 Sprays
- 1.3.4 Injectable Formulation
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Vitamin B12 Series API Market Dynamics
- 2.1 Vitamin B12 Series API Industry Trends
- 2.2 Vitamin B12 Series API Industry Drivers
- 2.3 Vitamin B12 Series API Industry Opportunities and Challenges
- 2.4 Vitamin B12 Series API Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Vitamin B12 Series API Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Vitamin B12 Series API Revenue by Region
- 3.2.1 Global Vitamin B12 Series API Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Vitamin B12 Series API Revenue by Region (2021-2026)
- 3.2.3 Global Vitamin B12 Series API Revenue by Region (2027-2032)
- 3.2.4 Global Vitamin B12 Series API Revenue Market Share by Region (2021-2032)
- 3.3 Global Vitamin B12 Series API Sales Estimates and Forecasts 2021-2032
- 3.4 Global Vitamin B12 Series API Sales by Region
- 3.4.1 Global Vitamin B12 Series API Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Vitamin B12 Series API Sales by Region (2021-2026)
- 3.4.3 Global Vitamin B12 Series API Sales by Region (2027-2032)
- 3.4.4 Global Vitamin B12 Series API Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Vitamin B12 Series API Revenue by Manufacturers
- 4.1.1 Global Vitamin B12 Series API Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Vitamin B12 Series API Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Vitamin B12 Series API Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Vitamin B12 Series API Sales by Manufacturers
- 4.2.1 Global Vitamin B12 Series API Sales by Manufacturers (2021-2026)
- 4.2.2 Global Vitamin B12 Series API Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Vitamin B12 Series API Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Vitamin B12 Series API Sales Price by Manufacturers (2021-2026)
- 4.4 Global Vitamin B12 Series API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Vitamin B12 Series API Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Vitamin B12 Series API Manufacturers, Product Type & Application
- 4.7 Global Vitamin B12 Series API Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Vitamin B12 Series API Market CR5 and HHI
- 4.8.2 2025 Vitamin B12 Series API Tier 1, Tier 2, and Tier 3
5 Vitamin B12 Series API Market by Type
- 5.1 Global Vitamin B12 Series API Revenue by Type
- 5.1.1 Global Vitamin B12 Series API Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Vitamin B12 Series API Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Vitamin B12 Series API Revenue Market Share by Type (2021-2032)
- 5.2 Global Vitamin B12 Series API Sales by Type
- 5.2.1 Global Vitamin B12 Series API Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Vitamin B12 Series API Sales by Type (2021-2032) & (K G)
- 5.2.3 Global Vitamin B12 Series API Sales Market Share by Type (2021-2032)
- 5.3 Global Vitamin B12 Series API Price by Type
6 Vitamin B12 Series API Market by Application
- 6.1 Global Vitamin B12 Series API Revenue by Application
- 6.1.1 Global Vitamin B12 Series API Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Vitamin B12 Series API Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Vitamin B12 Series API Revenue Market Share by Application (2021-2032)
- 6.2 Global Vitamin B12 Series API Sales by Application
- 6.2.1 Global Vitamin B12 Series API Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Vitamin B12 Series API Sales by Application (2021-2032) & (K G)
- 6.2.3 Global Vitamin B12 Series API Sales Market Share by Application (2021-2032)
- 6.3 Global Vitamin B12 Series API Price by Application
7 Company Profiles
- 7.1 EUROAPI
- 7.1.1 EUROAPI Company Information
- 7.1.2 EUROAPI Business Overview
- 7.1.3 EUROAPI Vitamin B12 Series API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 EUROAPI Vitamin B12 Series API Product Portfolio
- 7.1.5 EUROAPI Recent Developments
- 7.2 Eisai Co., Ltd
- 7.2.1 Eisai Co., Ltd Company Information
- 7.2.2 Eisai Co., Ltd Business Overview
- 7.2.3 Eisai Co., Ltd Vitamin B12 Series API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Eisai Co., Ltd Vitamin B12 Series API Product Portfolio
- 7.2.5 Eisai Co., Ltd Recent Developments
- 7.3 HTBA
- 7.3.1 HTBA Company Information
- 7.3.2 HTBA Business Overview
- 7.3.3 HTBA Vitamin B12 Series API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 HTBA Vitamin B12 Series API Product Portfolio
- 7.3.5 HTBA Recent Developments
- 7.4 North China Pharmaceutical Company
- 7.4.1 North China Pharmaceutical Company Company Information
- 7.4.2 North China Pharmaceutical Company Business Overview
- 7.4.3 North China Pharmaceutical Company Vitamin B12 Series API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 North China Pharmaceutical Company Vitamin B12 Series API Product Portfolio
- 7.4.5 North China Pharmaceutical Company Recent Developments
- 7.5 Ningxia Kingvit Pharmaceutical
- 7.5.1 Ningxia Kingvit Pharmaceutical Company Information
- 7.5.2 Ningxia Kingvit Pharmaceutical Business Overview
- 7.5.3 Ningxia Kingvit Pharmaceutical Vitamin B12 Series API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Ningxia Kingvit Pharmaceutical Vitamin B12 Series API Product Portfolio
- 7.5.5 Ningxia Kingvit Pharmaceutical Recent Developments
- 7.6 Cspc Holdings Company
- 7.6.1 Cspc Holdings Company Company Information
- 7.6.2 Cspc Holdings Company Business Overview
- 7.6.3 Cspc Holdings Company Vitamin B12 Series API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Cspc Holdings Company Vitamin B12 Series API Product Portfolio
- 7.6.5 Cspc Holdings Company Recent Developments
- 7.7 Yufeng Industry Group
- 7.7.1 Yufeng Industry Group Company Information
- 7.7.2 Yufeng Industry Group Business Overview
- 7.7.3 Yufeng Industry Group Vitamin B12 Series API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Yufeng Industry Group Vitamin B12 Series API Product Portfolio
- 7.7.5 Yufeng Industry Group Recent Developments
8 North America
- 8.1 North America Vitamin B12 Series API Market Size by Type
- 8.1.1 North America Vitamin B12 Series API Revenue by Type (2021-2032)
- 8.1.2 North America Vitamin B12 Series API Sales by Type (2021-2032)
- 8.1.3 North America Vitamin B12 Series API Price by Type (2021-2032)
- 8.2 North America Vitamin B12 Series API Market Size by Application
- 8.2.1 North America Vitamin B12 Series API Revenue by Application (2021-2032)
- 8.2.2 North America Vitamin B12 Series API Sales by Application (2021-2032)
- 8.2.3 North America Vitamin B12 Series API Price by Application (2021-2032)
- 8.3 North America Vitamin B12 Series API Market Size by Country
- 8.3.1 North America Vitamin B12 Series API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Vitamin B12 Series API Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Vitamin B12 Series API Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Vitamin B12 Series API Market Size by Type
- 9.1.1 Europe Vitamin B12 Series API Revenue by Type (2021-2032)
- 9.1.2 Europe Vitamin B12 Series API Sales by Type (2021-2032)
- 9.1.3 Europe Vitamin B12 Series API Price by Type (2021-2032)
- 9.2 Europe Vitamin B12 Series API Market Size by Application
- 9.2.1 Europe Vitamin B12 Series API Revenue by Application (2021-2032)
- 9.2.2 Europe Vitamin B12 Series API Sales by Application (2021-2032)
- 9.2.3 Europe Vitamin B12 Series API Price by Application (2021-2032)
- 9.3 Europe Vitamin B12 Series API Market Size by Country
- 9.3.1 Europe Vitamin B12 Series API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Vitamin B12 Series API Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Vitamin B12 Series API Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Vitamin B12 Series API Market Size by Type
- 10.1.1 China Vitamin B12 Series API Revenue by Type (2021-2032)
- 10.1.2 China Vitamin B12 Series API Sales by Type (2021-2032)
- 10.1.3 China Vitamin B12 Series API Price by Type (2021-2032)
- 10.2 China Vitamin B12 Series API Market Size by Application
- 10.2.1 China Vitamin B12 Series API Revenue by Application (2021-2032)
- 10.2.2 China Vitamin B12 Series API Sales by Application (2021-2032)
- 10.2.3 China Vitamin B12 Series API Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Vitamin B12 Series API Market Size by Type
- 11.1.1 Asia Vitamin B12 Series API Revenue by Type (2021-2032)
- 11.1.2 Asia Vitamin B12 Series API Sales by Type (2021-2032)
- 11.1.3 Asia Vitamin B12 Series API Price by Type (2021-2032)
- 11.2 Asia Vitamin B12 Series API Market Size by Application
- 11.2.1 Asia Vitamin B12 Series API Revenue by Application (2021-2032)
- 11.2.2 Asia Vitamin B12 Series API Sales by Application (2021-2032)
- 11.2.3 Asia Vitamin B12 Series API Price by Application (2021-2032)
- 11.3 Asia Vitamin B12 Series API Market Size by Country
- 11.3.1 Asia Vitamin B12 Series API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Vitamin B12 Series API Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Vitamin B12 Series API Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Vitamin B12 Series API Market Size by Type
- 12.1.1 SAMEA Vitamin B12 Series API Revenue by Type (2021-2032)
- 12.1.2 SAMEA Vitamin B12 Series API Sales by Type (2021-2032)
- 12.1.3 SAMEA Vitamin B12 Series API Price by Type (2021-2032)
- 12.2 SAMEA Vitamin B12 Series API Market Size by Application
- 12.2.1 SAMEA Vitamin B12 Series API Revenue by Application (2021-2032)
- 12.2.2 SAMEA Vitamin B12 Series API Sales by Application (2021-2032)
- 12.2.3 SAMEA Vitamin B12 Series API Price by Application (2021-2032)
- 12.3 SAMEA Vitamin B12 Series API Market Size by Country
- 12.3.1 SAMEA Vitamin B12 Series API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Vitamin B12 Series API Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Vitamin B12 Series API Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Vitamin B12 Series API Value Chain Analysis
- 13.1.1 Vitamin B12 Series API Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Vitamin B12 Series API Production Mode & Process
- 13.2 Vitamin B12 Series API Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Vitamin B12 Series API Distributors
- 13.2.3 Vitamin B12 Series API Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst